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ABSTRACT  
Differential diagnosis of chronic hair loss remains a challenge in dermatology. The 
aim of the study was to evaluate the value of a new scalp visualization technique, 
trichoscopy, in differential diagnosis of hair loss. Trichoscopy was performed in 131 
females (59 with androgenic alopecia, 33 with chronic telogen effluvium, 39 healthy 
controls).  
Based study results, a standardized trichoscopy report was developed and diagnostic 
criteria for female androgenic alopecia were established. Major criteria: increased 
number of yellow dots and thin hairs, as well as decreased average hair thickness in 
frontal area. Minor criteria: increased frontal area to occiput ratio of single-hair units 
(>2:1), vellus hairs (>1,5:1) and follicles with perifollicular discoloration (>3:1) 
Fulfillments of 2 major criteria or 1 major and 2 minor is diagnostic for female 
androgenic alopecia with a 92% specificity. 
In conclusion, trichoscopy is the first method which allows differential diagnosis of 
hair loss and establishing the diagnosis of female androgenic alopecia.  
 
 
 
 
 
 
 
 
 
 
INTRODUCTION  
Chronic hair loss frequently affects female patients, but there is little or no objective 
technology available to aid the dermatologist in setting a proper diagnosis and in 
monitoring treatment efficacy.1 In particular, it may be difficult to differentiate between 
female androgenic alopecia (FAGA), a subtype of female pattern hair loss, and 
chronic telogen effluvium (CTE).2 Common coexistence of these two diseases makes 
the diagnosis an even bigger challenge. 
Telogen effluvium is a self-limiting process and almost never causes obvious 
baldness,3 whereas FAGA progresses in time, leading to a significant decrease in 
hair thickness, which over time may become cosmetically unacceptable and 
psychologically frustrating.4 Differences in natural history, prognosis and emerging 
new therapeutic possibilities 5 make differential diagnosis and early diagnosis of 
FAGA especially important. Currently the diagnosis of FAGA is usually based on 
anamnesis and clinical findings, such as pattern of increased hair thinning, retention 
of the frontal hairline, and the presence of miniaturized hairs.6,7 The semi-invasive 
technique of hair root analysis (trichogram) has a decreasing number of advocates 
among dermatologists. It is considered poor indicator of FAGA and it's severity.8 
Additionally, the test should be performed 5 days after shampooing, what is 
unpleasant for patients.  
A scalp biopsy examination is performed usually to confirm the diagnosis of FAGA in 
clinically doubtful cases.2,3 Histopathology findings in FAGA include a decrease in 
terminal/vellus hair ratio and decline in mean total follicle count with increasing grade 
of hair loss. This method also has limitations in everyday practice. Typically, punch 
biopsies are taken for vertical and horizontal embedding. These are 7-12mm2 in size 
and contain only a small number of hair follicles. Thus, some authors suggest 
performing multiple biopsies for representative sampling, what increases the 
invasiveness of this diagnostic technique and makes it even less useful for 
monitoring of treatment efficacy.8 
Trichoscopy 9,10 is  newly developed method of hair image analysis, based on 
videodermoscopy of hair and scalp. The method allows visualization of hair shafts at 
high magnification and performing measurements, such as hair shaft thickness, 
without the need of removing hair for diagnostic purposes. It also allows in vivo 
visualization of the epidermal portion of hair follicles and perifollicular epidermis.11,12 
Several reports raise the issue of potential usefulness of this technique in diagnosing 
hair and scalp disorders, such as androgenic alopecia,13,14 alopecia areata,15,16 
lipedematous alopecia,17 pediculosis 18 or inherited hair shaft abnormalities,19 but the 
metod has not been standardized yet and no criteria for diagnosing acquired 
diseases of hair and scalp have been established. 
The aim of the study was to establish a standardized method of trichoscopy in 
acquired hair loss and to establish trichoscopy criteria for diagnosing FAGA.  
A total of 131 female patients were included into the study, 59 with clinically evident  
FAGA, 33 with CTE confirmed by trichogram and 39 healthy volunteers. 
The mean age was 36.2 (18-59) years in patients with FAGA, 32.2 (18-56) years in 
patients with chronic telogen effluvium and 37.8 (19-58) years in healthy controls. 
The differences were statistically not significant.  
 
RESULTS  
Statistical analysis was performed with the use of t-Student test for paired samples 
and with analysis of variance (ANOVA). The Classification and Regression Tree 
technique was used to establish diagnostic criteria. The study design was approved 
by the ethical committee.  
Hair thickness 
Both, in the healthy controls, as well as in patients with chronic telogen effluvium, the 
thickest hairs have been observed in the frontal area, whereas the thinnest in the 
occipital area. In the healthy control group mean hair thickness was 0.061 
mm±0.008mm in frontal area vs 0.058±0.007mm in occipital area (p<0.001). In 
telogen effluvium the values were 0.056±0.007mm vs 0.053±0.009mm respectively  
(p<0.001). In the FAGA the smallest average thickness of hair roots has been 
observed in the frontal area with 0.047±0.007mm compared to 0.052±0.008mm in the 
occipital area (p<0.001). In patients with FAGA average hair thickness in the left 
temporal area of was 0.05±0.009mm and in the right temporal area 0.051±0.008mm 
(Figure 1). 
Differences between left and right temporal area were statistically not significant. No 
significant differences in results between the left and right temporal area were 
established in any of the investigated parameters. Thus, results for only one (left) 
temporal area are presented in figures. 
In all assessed areas the smallest average thickness of the hair roots has been noted 
in patients with FAGA. Compared to healthy controls, hair thickness of patients with 
FAGA was significantly reduced in the frontal (p<0.001), occipital (p=0.002), left 
temporal (p<0.001) and right temporal area (p<0.001). Detailed results are presented 
in Figure 1. 
The largest average percentage of thin hairs (below 0,03 mm) was observed in FAGA 
in frontal area (20.9±12%) and it was significantly different compared to patients with 
telogen effluvium (10.4±3.9%) and healthy volunteers (6.15±4.6%, p< 0.001). An 
increase in the percentage of thin hairs was accompanied by an increase in the 
proportion of medium-size hairs and a simultaneous decrease in the proportion of 
thick hairs. As the process occurred, the shift towards an increase of vellus hairs has 
been also observed in the occiput of FAGA patients. 
The mean proportion of thin, medium-size and thick hairs in occipital area of FAGA 
patients was 14.2±8.9%, 31.5±15.8% and 54±4.9% respectively. In the control group 
the respective proportions were 6±5.1%, 20.6±13.4% and 73.4±5.8%. In telogen 
effluvium the respective values were 11.9±3.9%, 29.7±15.9% and 58.6±8.5%. 
Detailed results are presented in Figure 2. 
Image analysis showed that vellus hairs (hairs below 0.03 mm) differ in chronic 
telogen effluvium from FAGA by being short and sharp-ended (Figure 3C,D), as in 
regrowing hairs rather than longer and bluntly ended as in progressive hair follicle 
miniaturization (Figure 3 A,B). A number of five or more short and sharp-ended hairs 
in 4 fields of vision at 70-fold magnification in both the frontal and occipital or 
temporal area was found in 18/33 (54.5%) patients with CTE and in none of the 
patients with FAGA. 
Pilosebaceous units 
Hairs usually are present in groups of few hair roots growing from one follicular 
orifice. The number of hairs in pilosebaceous units has been evaluated by 
trichoscopy at the 20-fold magnification. The percentage of single-hair, double-hair 
and triple-hair units was evaluated. 
In healthy controls and in chronic telogen effluvium the highest proportion of single-
hair pilosebaceous units was observed in the temporal areas. The mean percentage 
of single-hair units in this area was 42±12% in CTE and 32±15% in healthy controls. 
In patients with FAGA the mean percentage of single-hair pilosebaceous units was 
highest in the frontal area (65.2±19.9%). This was significantly more than in telogen 
effluvium (39.0±13.4%, p<0.001) and in healthy controls (27.3±13%, p<0.001). The 
smallest difference between these groups in the proportion of single-hair 
pilosebaceous units has been noted in the occipital region. The numbers for healthy 
controls, FAGA and telogen effluvium were 22.6±12.6%, 36.8±18.6% and 31±23% 
respectively. The difference between FAGA and healthy control was statistically  
significant at p<0.001. The mean proportion of single-hair units in the frontal area to 
occipital area was 2.56 in healthy controls, 3.4 in telogen effluvium (p=0.01) and 10.4 
in FAGA (p<0.001). 
Detailed results showing the proportion of single-, double- and triple-hair 
pilosebaceous units in healthy donors and FAGA are presented in Figure 4. Units 
with 4 hairs accounted for less than 1% of the total number of evaluated units and 
were omitted in this figure. 
"Yellow dots" 
“Yellow dots” were evaluated at 20-fold magnification and at 70-fold magnification. 
Results are given as total number of yellow dots in one field of vision (FOV) at 20-fold 
magnification and as total number seen in four FOVs at 70-fold magnification. In both 
calculation methods the number of yellow dots was significantly higher in patients 
with FAGA as compared to healthy controls or to patients with CTE. However, in 
general, the number of yellow dots per 1mc2 was on average 20% higher when 
evaluated at 70-fold magnification, as compared to 20-fold magnification. This 
difference resulted from better visualization of small trichoscopy structures at higher 
magnifications. Figure 5 shows the mean numbers of yellow dots in healthy controls, 
FAGA and telogen effluvium, when analyzed in four fields of vision at 70-fold 
magnification. The highest number of yellow dots in patients with FAGA was noted in 
the frontal area (8.86±4.8/4 fields of vision at 70-fold magnification). The 
corresponding number in the occipital area was 1.59±2.0. 
Perifollicular discoloration 
The percentage of hair-containing units with perifollicular discoloration was evaluated 
at 20-fold magnification and in 4 FOVs at 70-fold magnification. Both methods yielded 
highly comparable results. Thus, results are presented for the 20-fold magnification 
only. 
Perifollicular discoloration was found significantly more often in FAGA as compared to 
healthy controls or patients with CTE. The mean percentage of hair follicles with 
surrounding discoloration in FAGA was 32.4±4.7% in the frontal area and 6.6±2% in 
the occipital area (p<0.001).  
Other parameters 
Other parameters (white dots, cadaverized hairs, broken hairs, degree of 
desquamation, predominant type of blood vessels, presence exclamation mark hairs) 
were evaluated in accordance with the study outline presented in the Materials and 
Methods section and gave results which were non-significant for setting up criteria for 
diagnosis of FAGA. No differences in the frequency of their occurrence have been 
demonstrated between the respective areas of the scalp. These results are not 
presented. 
Differences between the frontal and occipital area. 
The two-tailed testing method with 95% confidence interval was used for comparing 
trichoscopy results obtained for the frontal area to the occipital area. These 
differences were most profound in patients with FAGA. 
In healthy controls mean hair thickness was significantly lower in the frontal area 
(t(38)=4.78; p<0.001) and the percentage of single-hair units was significantly higher 
(t(38)=2.56; p=0.01) as compared to the occipital area. 
Similar results were obtained in patients with telogen effluvium. Statistically significant 
differences were noted only in mean hair thickness (t(32)=4.06; p<0.001) and 
percentage of single-hair units (t(32)= 3.40; p <0.001). The frontal area in FAGA 
patients was characterized by a lower percentage of pilosebaceous units with three 
hairs (t(58)= -5.18; p<0.001) and two hairs (t(58)= -8.19; p<0.001), higher percentage 
of single-hair units (t(58)= 10.40; p<0.001) and vellus hairs (t(58)= 5.70; p <0.001). 
The frontal area in these patients was also characterized by a lowered percentage of 
thick hairs measuring more than 0.050mm (t(58)= -6.15; p <0.001) and higher 
percentage of follicles with perifollicular discoloration (t(58)= 6.12; p <0.001) or follicle 
ostia presenting as yellow dots (t(58)=11.63; p<0001) as compared to the occipital 
area. Mean hair thickness was significantly lower in scalp front as compared to the 
occiput (t(58)= -6.86; p <0.001). 
The ratio of vellus hairs in the frontal area to occipital area (calculated in four fields of 
vision at 70-fold magnification) was 2.21±1.28 (mean±SD) in FAGA, 1.40±0.59 in 
telogen effluvium and 1.43±0.83 in healthy volunteers. The difference between FAGA 
and either healthy controls or telogen effluvium was statistically significant at p<0.001 
in both cases. The difference between healthy controls and telogen effluvium was 
statistically not significant. 
Clasification and Regression Tree 
Data obtained in this study were used to define diagnostic trichoscopy criteria for 
FAGA by employing a Classification and Regression Tree analysis. These allowed to 
define 3 major and 3 minor criteria into an algorithm, which gave a 98% metod 
specificity for FAGA. 
Major Criteria 
1. More than 4 yellow dots in 4 images at 70-fold magnification in the frontal area. 
2. Lower average hair thickness in the frontal area in comparison to the occiput 
(calculated from not less than 50 hairs from each area). 
3. More the 10% of thin hairs (below 0.03mm) in the frontal area 
Minor criteria 
1. ratio of single-hair units percentage, frontal area to occiput > 2:1 
2. ratio of number of vellus hairs, frontal area to occiput > 1,5:1 
3. ratio of hair follicles with perifollicular discoloration, frontal area to occiput > 3:1 
Fulfillment of 2 major criteria or 1 major and 2 minor criteria is required to diagnose 
FAGA based on trichoscopy. 
In order to confirm this diagnostic model a linear regression analysis was performed 
in which the dependent variable was the diagnosis of FAGA and the diagnostic 
criteria were independent variables. An analytical model, which was constructed this 
way showed a potential diagnostic sensitivity of this method at the level of 72%. 
Trichoscopy report 
Based on results collected in this study we established a trichoscopy report form 
which contains most important trichoscopy findings in diffuse hair loss and diagnostic 
criteria for FAGA (Table 1). Elements, which were not found to be of diagnostic value 
in this or previous studies (Lacarrubba et al, 2004; Ross et al, 2006) were not 
included into this trichoscopy report form. These include trichoscopy results from 
parietal regions and results from magnifications which were less precise or 
significantly less comfortable to handle. We also found evaluation of distance 
between pilosebaceous units not useful for diagnostic purposes. This trichoscopy 
report contains a simplified field for specific signs of inherited hair shaft abnormalities, 
cicatricial alopecia and alopecia areata. 
 
DISCUSSION 
FAGA, a disease in the spectrum of female pattern hair loss, is characterized by 
progressive miniaturization of hair follicles, mediated most probably by 
dihydrotestosterone within the follicle and may affect women with normal levels of 
circulating androgens.20 The diagnosis is usually based on anamnesis and clinical 
findings, such as early age of onset, the pattern of increased hair thinning over the 
frontal/parietal scalp with greater hair density over the occipital scalp, retention of the 
frontal hairline, and the presence of miniaturized hairs.6,7,21 Histologically, the disease 
is characterized by miniaturization of a proportion of follicles and an increased 
percentage of hair in telogen in the affected area.7 In advanced stages of disease, 
when these features are obvious, the diagnosis is not problematic. However, in early 
disease and in patients, in whom other causes of hair loss coexist the diagnosis may 
be challenging. 
In this study trichoscopy criteria were established, which allow to diagnose FAGA with 
92% specificity. These criteria are based on findings, which have partly been known 
from clinical observations and other diagnostic methods, but could not be quantified 
before trichoscopy was developed. These findings relate to predominance of hair 
miniaturization in the frontal area compared to the occiput. 
This clinical and histopathological observation has been identified and quantified by 
trichoscopy as lower average hair thickness in the frontal area in comparison to the 
occiput, more the 10% of thin hairs (below 0.03 mm) in the frontal area and ratio of 
vellus hair number (frontal area to occiput) above 1.5:1. 
A novel approach to quantify hair density in practical dermatology is evaluation of the 
number of hairs in one pilosebaceous unit. This was previously not possible with 
classical diagnostic method or the recently developed phototrichogram.22 The 
number of hairs in one pilosebaceous unit varies from 1-3 in healthy persons. 
Occasionally a four-hair units may be found. Our results show that the number of 
single-hair pilosebaceous units is significantly increased in patients with FAGA and 
the number of single-hair units in these patients is significantly higher in the frontal 
area compared to the occiput. A ratio of single-hair units in frontal area to occiput 
above 2:1 was found to be highly indicative of FAGA. Hair thinning, decreased 
number of hairs in pilosebaceous units and predominant prevalence in the frontal 
area are main features distinguishing FAGA from most other hair diseases, especially 
alopecia areata.11  
Clinically "patterning" in patients with female pattern hair loss may be with frontal 
accentuation ("Christmas tree" pattern), diffuse central or vertex/frontal (male pattern) 
with sparing of the occiput.6 Recently, studies have demonstrated that in patients with 
FAGA changes observed in the occiput are similar to those in the frontal area, but 
less pronounced. Using the phototrichogram method, both Ekmekci23 and Van Neste1 
showed decreased hair density and an increased percentage of thin hair roots 
(<0.04mm) in the occipital area of FAGA patients, compared to healthy controls. Our 
results confirm the occurrence of changes typical for androgenic alopecia also in 
other areas than those considered “androgen- dependent”. We have shown that in 
the occipital area of patients with FAGA average hair diameter is significantly 
decreased, the percentage of vellus hairs is increased and the number of single-hair 
pilosebaceous units is higher than in the occipital area of healthy controls. Also other 
features of FAGA, such as yellow dots and perifollicular discoloration were found in 
the occipital area of patients with FAGA, but not in healthy controls. Assessment of 
these trichoscopy features in temporal areas gave intermediate values between 
results obtained for the frontal region and the occiput in both FAGA and chronic 
telogen effluvium. It may be concluded that trichoscopy of temporal areas may be 
ignored in dermatological practice. Trichoscopic examination of the frontal area and 
the occiput is sufficient for diagnostic purposes and to monitor disease progression. 
Interestingly, it has been observed in healthy controls that the temporal areas have 
the highest number vellus hairs and pilosebaceous units with only one hair, indicating 
that physiologically these areas have lowest hair density. 
A major trichoscopy criterion of FAGA is the presence of yellow dots, which reflect 
hair follicle ostia lacking any hairs (“empty hair follicles”). It may be suggested that 
yellow dots in FAGA result from the presence of sebaceous lobules, which in 
histopathology appear large in relation to the miniaturized follicles.24 We hypothesize 
that these sebaceous glands are still active after advanced hair follicle miniaturization 
and produce sebum which creates intraepidemal sebum lagoons. Theses sebum 
lagoons appear as yellow dots in trichoscopy. We found that the number of yellow 
dots is significantly increased in patients with FAGA and that in these patients the 
number of yellow dots is significantly higher in the frontal area compared to the 
occipital area. 
Yellow dots have been previously described in alopecia areata11,12 and have been 
recently suggested as indicative of alopecia areata incognita (Kligman's telogen 
effluvium) in patients with diffuse hair loss.16 Our results show that yellow dots may 
be characteristic for a wide spectrum of hair diseases and they may also represent a 
wider, than previously anticipated, spectrum of histopathological appeareances of 
follicle ostia and infundibula. Our results show that yellow dots are not only present in 
most patients with FAGA but also that they are one of the most important trichoscopy 
features distinguishing FAGA from chronic telogen effluvium. 
Another important trichoscopy finding is perifollicular darkening (discoloration) of the 
skin. This feature, called by some authors "hiperpigmentation" or "peripilar sign" is 
according to Deloche 25  reflecting the presence of perifollicular lymphocytic infiltrates 
in early androgenic alopecia. Our results confirm the presence of perifollicular 
discoloration in androgenic alopecia. However, it is not specific for androgenic 
alopecia. Our results show that it may be present, in a minor degree, also in chronic 
telogen effluvium. Ross at al.12 described presence of perifolllicular 
hyperpigmentation in some patients with alopecia areata. 
Though, we found that in FAGA the percentage of hair follicles with this  abnormality 
is significantly higher in the frontal area compared to the occiput. According to 
statistical analysis a ratio of hair follicles with perifollicular discoloration, frontal area 
to occiput higher than 3:1 is highly indicative of FAGA. Classification and Regression 
Tree analysis allowed to define trichoscopy criteria for FAGA. 
Major Criteria are: 1. More than 4 yellow dots in 4 fields of vision at 70-fold 
magnification in the frontal area, 2. Lower average hair thickness in the frontal area in 
comparison to the occiput (calculated from not less than 50 hairs from each area), 3. 
More the 10% of thin hairs (below 0.03 mm) in the frontal area. Minor criteria are: 1. 
ratio of single-hair units percentage, frontal area to occiput above 2:1, 2. ratio of 
vellus hair number, frontal area to occiput above 1.5:1, 3. ratio of hair follicles with 
perifollicular discoloration, frontal area to occiput above 3:1. Fulfillment of 2 major 
criteria or 1 major and 2 minor criteria allows diagnosing FAGA with a 98% specificity. 
A standardized trichoscopy report was developed to facilitate trichoscopy 
examinations and simplify evaluation of FAGA diagnostic criteria. This trichoscopy 
report also contains a separate field for specific signs of inherited hair shaft 
abnormalities, cicatricial alopecia and alopecia areata. The method is simple to use 
and may be applied as accessory tool in differential diagnosis of hair loss in 
dermatological practice. 
It may also be applied in monitoring disease progression and treatment efficacy. 
Chronic telogen effluvium has no specific trichoscopy features, apart from an 
increased proportion of short, sharp-ended hairs. A number of five or more in 4 fields 
of vision at 70-fold magnification in both the frontal and another (occipital or temporal) 
was found highly indicative of CTE. Most likely these are regrowing hairs in early  
anagen stage and their increased number indicates an accelerated hair cycle, 
resulting in an intensive replacement of hair roots. However, chronic telogen 
effluvium may be rather a diagnosis made by exclusion of other causes of hair loss, 
than by direct fullfilment of specific trichoscopy criteria.  
In conclusion, the results of our study indicate that the diagnosis of FAGA may be 
established based solely on trichoscopy criteria and this method seems to be the only 
which anables to confirm or exclude female androgenic alopecia.  
 
METHODS SUMMARY  
Trichoscopy has been performed with the Fotofinder II videodermoscope, which 
permits scalp visualization at 20-160-fold magnification. The device is equipped with 
software which allows to carry out measurements of structures visualized in 
magnified images and provides results in real scale. Images of the scalp were taken 
at a 20-fold magnification which allows high quality enlargement of 1cm2 of scalp 
area to the size of a computer screen and at 70-fold magnification which magnifies in 
a similar manner an area of 9mm2. 
In each patient one image at 20-fold magnification and 4 images at 70-fold 
magnification were taken each of following four areas: frontal, occipital, right temporal 
and left temporal. 
Hair thickness was measured at 70-fold magnification, in direct proximity to follicular 
orifices. Hairs have been identified as “thin hairs” (below 0.03 mm), “medium- size 
hairs” (0.03-0.05 mm) and “thick hairs” (above 0.05 mm). 
The images have been evaluated in accordance with the scheme:   
1. Number of vellus hairs in one field of vision (FOV) at 20-fold magnification and in 
four FOVs at 70-fold magnification 
2. Hair thickness: 
- percentage of thin hairs (less than 0.03 mm) 
- percentage of medium sized hairs (0.03 mm to 0.05 mm) 
- percentage of thick hairs (above 0.05) 
- mean hair thickness (mm) 
3. Percentage of pilosebaceous units with 1,2 and 3 hairs calculated at 20-fold 
magnification  
4. Number of yellow dots per FOV calculated at 20-fold magnification and in four 
fields ofvision at 70-fold magnification 
5. Percentage of perifollicular yellow discoloration (hyperpigmentation) calculated at 
20-fold magnification 
6. Other: 
- number of white dots (scarified follicular ostia), cadaverized hairs, broken hairs, 
- type of blood vessels, 
- presence of exclamation mark hairs 
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TABLES:  
Table 1. Trichoscopy report scheme. 
  
     Frontal 
area   
Occiput  FAGA criteria    
Total number of yellow
dots in four fields of
vision*     
          > 4 in frontal area    
Mean hair thickness
(mm)*     
           Lower in frontal area  
Percentage of hairs*:              
1) thin hairs  (<0,03mm)              
2) medium sized hairs 
(0.03-0.05mm)     
          
     
     
 Major 
Criteria    
3) thick hairs (>0,05mm)              
More than 10% thin 
hairs in frontal area    
Percentage of units in one
field of vision**    
         
     
1) single-hair            
2) two-hair units             
3) tree-hair units            
Ratio of single-hair 
units, frontal area to 
occiput > 2:1    
Total number of vellus hairs
in four fields of vision*     
          Ratio frontal area to 
occiput > 1,5:1    
     
     
  Minor 
Criteria     
Percentage hair follicles with
perifollicular discoloration**   
          Ratiofrontal area to 
occiput  > 3:1    
     Other observations     
(i.e. exclamation hairs,     
cadaverized hairs, white 
dots)     
     
     
     
                * 70-fold magnification, ** 20-fold magnification   
 
 
 
FIGURE LEGENDS:  
Figure 1. Mean hair diameter in frontal, occipital and left temporal areas of patients 
with female androgenic alopecia (FAGA), chronic telogen effluvium (CTE) and 
healthy controls. Asterix indicates the most important, statistically significant 
differences between (p<0.001). 
Figure 2. Percentage of thin, medium-sized and thick hairs in frontal and occipital 
areas in healthy controls, female patients with androgenic alopecia (FAGA) and 
chronic telogen effluvium (CTE). Statistically significant differences (p<0.05) in the 
distribution of hair thickness between the studied groups have been marked by an 
asterix.  
Figure 3. Trichoscopy of frontal scalp area in a patient with FAGA (A,B) and chronic 
telogen effluvium (C,D), presented in 70- fold (A,C) and 20- fold magnification (B,D). 
Red asterix points to yellow dots. Red arrows point to vellus hairs in FAGA, which are 
longer and bluntly ended compared to short and sharp-ended thin hairs in CTE 
(pointed by green arrows).  
Figure 4. Percentage distribution of pilosebaceous units with one, two and three 
hairs. In chronic telogen effluvium (CTE) patients as well as in the healthy control the 
distribution was similar. Thus, only healthy control results and patients with FAGA are 
presented in this diagram.  
Figure 5. Yellow dots in frontal, occipital and left temporal area of all 3 groups 
ofpatients, presented as a number counted in 4 FOV`s at 70- fold magnifications. The 
highest number of yellow dots has been noted in patients with FAGA in the frontal 
area. Asterixs mark statistically significant differences (p<0.001).  
 





